Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 3,429 shares at $56.05 ($191K) on 2008-02-19, disclosed to the SEC on 2008-02-20.
Scheduled sale ($191k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.55 | 1,865 | $104K | 54.3% |
| 2 | $55.55 | 746 | $41K | 21.7% |
| 3 | $56.05 | 818 | $46K | 24.0% |
| Total | $55.67 avg | 3,429 | $191K | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |